Skip to main content
. 2018 Feb 7;35(3):32. doi: 10.1007/s12032-018-1087-6

Table 3.

Grade 3 to 4 treatment-related adverse events

Adverse event Number of patients (%)
All 38
Anemia 4 (10.5%)
Neutropenia 5 (13.2%)
Hypomagnesemia 9 (23.7%)
Hypokalemia 5 (13.1%)
Acne-like rash 5 (13.1%)
Allergic reaction 2 (5.3%)
Diarrhea 2 (5.3%)
Nausea 3 (7.9%)
Pneumonia 2 (5.3%)
MRSA plus fever 1 (2.6%)